Company profile: LimFlow
1.1 - Company Overview
Company description
- Provider of minimally invasive vascular devices for chronic limb-threatening ischemia. The LimFlow System diverts blood around blocked arteries into tibial veins to restore foot perfusion, and includes the LimFlow ARC arterial catheter, V-Ceiver venous catheter, Vector valvulotome, Extension Covered Stents, and Crossing Stents. Approved in CE Mark markets; investigational use only in the U.S.
Products and services
- LimFlow System: CE-marked, minimally-invasive system that restores blood flow to ischemic feet in CLTI by diverting blood around blocked arteries into the tibial veins
- Crossing Stents: Custom-engineered stents that create a channel for blood to move from artery to vein, with sizing optimized for both vessels to maximize flow
- Extension Covered Stents: Venous-optimized, PTFE-covered nitinol stents engineered to maximize outflow to the foot by keeping valves open and blocking smaller veins
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LimFlow
Crux Biomedical
HQ: United States
Website
- Description: Provider of biotech solutions addressing the clinical limitations of current vena cava filters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crux Biomedical company profile →
InspireMD
HQ: United States
Website
- Description: Provider of medical device solutions focused on proprietary stent system technology (MGuard), including CGuard EPS, a carotid stent using MicroNet mesh to trap and seal thrombus and plaque to help prevent stroke, and SwitchGuard NPS, a neuroprotection system intended for Transcarotid Artery Revascularization (TCAR) procedures, currently under clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InspireMD company profile →
CV Ingenuity
HQ: United States
Website
- Description: Provider of drug-coated balloon platforms for the “Touch-and-Go” treatment of vascular diseases, developing devices to relieve vascular obstructions, inhibit restenosis, and enable natural vessel healing; Palo Alto, CA-based.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CV Ingenuity company profile →
Carmeda
HQ: Sweden
Website
- Description: Provider of hemocompatible surface coating for medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmeda company profile →
Armetheon
HQ: United States
Website
- Description: Provider of cardiovascular-focused, late-clinical stage specialty pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Armetheon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LimFlow
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LimFlow
2.2 - Growth funds investing in similar companies to LimFlow
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LimFlow
4.2 - Public trading comparable groups for LimFlow
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →